The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
In the present double blind, placebo-controlled, parallel study we evaluated the impact of 12
weeks thiazolidinedione (TZD) administration on basal and insulin-stimulated substrate
metabolism in growth hormone-replaced adults with growth hormone deficiency.